Advertisement

Topics

Celgene-backed CRISPR company emerges with $68M Series A

03:08 EDT 23 Jun 2017 | BioPharmaDive

The startup Repare Therapeutics comes out of stealth mode with a preclinical pipeline already in place.

Original Article: Celgene-backed CRISPR company emerges with $68M Series A

NEXT ARTICLE

More From BioPortfolio on "Celgene-backed CRISPR company emerges with $68M Series A"

Advertisement
Quick Search
Advertisement
Advertisement